View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Trastuzumab 6 / Abemaciclib 150 / Fulvestrant 500, Breast Cancer, Cycle 2+
Protocol-ID: 1602 V1.1 (Mini), TRAS6/ABEM150/FLVS500, Breast Ca, C2+Indication(s)
- Breast Cancer (HR+, HER2+); ICD-10 C50.-
Links
- Abemaciclib [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 12.10.2021